PRESS RELEASES More events are coming soon. Keyword Search Year: 2019201820172016201520142013 05/30/19 Summary ToggleTRACON Pharmaceuticals to Present at the Jefferies 2019 Healthcare Conference Printer Friendly PDF Version 05/14/19 Summary ToggleTRACON Pharmaceuticals Reports First Quarter 2019 Financial Results and Provides Corporate Update Printer Friendly PDF Version 05/07/19 Summary ToggleTRACON to Report First Quarter 2019 Company Highlights and Financial Results on May 14, 2019 Printer Friendly PDF Version 04/12/19 Summary ToggleTRACON Pharmaceuticals Announces Termination of Phase 3 TAPPAS Trial Based on the Recommendation of the Independent Data Monitoring Committee Printer Friendly PDF Version 03/27/19 Summary ToggleTRACON Pharmaceuticals Announces TRC105, TRC253 and TRC102 Data Presentations at Upcoming AACR Annual Meeting Printer Friendly PDF Version 02/28/19 Summary ToggleTRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2018 Financial Results and Provides Corporate Update Printer Friendly PDF Version 02/21/19 Summary ToggleTRACON to Report Fourth Quarter and Full Year 2018 Company Highlights and Financial Results on February 28, 2019 Printer Friendly PDF Version 01/22/19 Summary ToggleTRACON Pharmaceuticals Announces Positive Data from Ongoing Phase 1b/2 Trial of TRC105 in Hepatocellular Carcinoma Printer Friendly PDF Version 01/18/19 Summary ToggleI-Mab Biopharma Receives U.S. FDA IND Clearance for Proprietary CD73 Antibody TJD5 Printer Friendly 12/26/18 Summary ToggleTRACON Pharmaceuticals Presents Positive Top-line Clinical Data from Dose Escalation Portion of Phase 1 Trial of TRC105 and Opdivo® for Treatment of Non-Small Cell Lung Cancer Printer Friendly PDF Version Pagination Current page 1 Page 2 Page 3 Page 4 … Next page Next Last page Last
